Watson to commercialize Antares OAB gel in US, Canada
As per the terms of the agreement, Antares Pharma is entitled to receive milestone payments on achieving regulatory approval and certain sales level from Watson. Antares Pharma is
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.